Home - Products - Others - Other Targets - 1-Methylnicotinamide chloride

1-Methylnicotinamide chloride

CAS No. 1005-24-9

1-Methylnicotinamide chloride ( 1-methylpyridin-1-ium-3-carboxamide hydrochloride;3-Carbamoyl-1-methylpyridinium Chloride;Nicotinamide Chloromethylate )

Catalog No. M19773 CAS No. 1005-24-9

Niacin metabolite excreted via the urinary system.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 35 In Stock
200MG 50 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-Methylnicotinamide chloride
  • Note
    Research use only not for human use.
  • Brief Description
    Niacin metabolite excreted via the urinary system.
  • Description
    Niacin metabolite excreted via the urinary system.
  • Synonyms
    1-methylpyridin-1-ium-3-carboxamide hydrochloride;3-Carbamoyl-1-methylpyridinium Chloride;Nicotinamide Chloromethylate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1005-24-9
  • Formula Weight
    172.62
  • Molecular Formula
    C7H9ClN2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    [Cl-].C[n+]1cccc(c1)C(N)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Lithium potassium ac...

    Acetyl phosphate is a compound involved in taurine and hypotaurine metabolism as well as pyruvate metabolism. It is generated from sulfoacetaldehyde converted to acetyl-CoA and acetate via phosphate acetyltransferase and acetate kinase respectively. It is also an intermediate in pyruvate metabolism.

  • Mafenide Acetate

    Mafenide Acetate is a sulfonamide-type medication??inhibits the enzyme carbonic anhydrase and is used as topical anti-infective especially in burn therapy.

  • Pilloin

    Pilloin exerts a cytotoxic action targeted at the transformed lymphoblasts.